Navigation Links
EORTC BOS 2 trial opens for patients with resectable liver metastases from colorectal cancer
Date:6/4/2013

Colorectal cancer (CRC) is the second most frequent cause of cancer-related mortality in both Europe and the United States. Treatment for patients with resectable hepatic metastases from colorectal cancer consists of surgery combined with chemotherapy, but recurrence is observed in two thirds of these patients. In order to improve the outcome for these patients, EORTC trial 40091 BOS 2 will test the efficacy of adding bevacizumab or panitumumab to the standard treatment, peri-operative FOLFOX 4 chemotherapy.

Bevacizumab is a monoclonal antibody which targets the vascular endothelial growth factor (VEGF), and blocking VEGF could deprive the cancer of required nutrients. Panitumumab targets the epidermal growth factor receptor (EGFR). EGFR gene expression is upregulated in approximately 60 to 80% of CRC cases, and this has been linked to poor survival.

Dr. Bernard Nordlinger, CHU Ambroise Pare AP-HP, Boulogne-Billancourt and Coordinator of this study, says "The objective of this trial is to determine a new standard of care for these patients." The randomized phase 2 EORTC trial will investigate if treatment with perioperative modified FOLFOX6 plus either bevacizumab or panitumumab improves progression-free survival and pathological response in patients with up to eight resectable liver metastases resulting from wild type KRAS CRC as compared to treatment with perioperative modified FOLFOX 6 alone.

Dr. Stephane Benoist, Assistance Publique, Hpitaux de Paris, Hopital De Bicetre AP-HP, Le Kremlin Bicetre and co-Coordinator of this study, says "Following the EPOC study, perioperative FOLFOX chemotherapy became the new standard of care in many countries for patients with resectable colorectal liver metastases. Nevertheless, most patients developed recurrence despite perioperative FOLFOX chemotherapy. One of the ways to improve long term prognosis is to intensify the perioperative chemotherapy. The BOS 2 study addresses a major clinical ques
'/>"/>

Contact: John Bean
john.bean@eortc.be
European Organisation for Research and Treatment of Cancer
Source:Eurekalert

Page: 1 2

Related medicine news :

1. EORTC study shows radiotherapy and surgery provide regional control for breast cancer patients
2. Markers in Cancer, a joint meeting by ASCO, EORTC & NCI, 7-9 Nov 2013 (diagnostic tutorial on 5-7)
3. EORTC study identifies patients with anaplastic oligodendroglioma that benefit from adjuvant PCV
4. EORTC led intergroup trial investigates Imatinib failure-free survival in patients with GIST
5. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
6. New Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research near Orlando, Florida; Accepting M/F Patients with Hep C Age 18-65
7. Low Back Pain Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with Chronic Low Back Pain Age 18-80
8. DePuy ASR Hip Implant Lawyers at Wright & Schulte LLC Pleased with Judge’s Decision to Uphold $8.3 Million Award in California DePuy ASR Hip Lawsuit Trial
9. True-Dose Pets Launches New Trial-Sized Product Line
10. Vaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pretrial Order in Federal Transvaginal Mesh Litigation
11. CureLauncher Introduces Personalized Clinical Trial Matching Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... York, New York (PRWEB) December 21, 2014 ... ) and other product liability claims involving a ... incretin mimetics continue to move forward in a ... Court, Southern District of California, Bernstein Liebhard LLP ... the Court has established a data cut-off date ...
(Date:12/21/2014)... Serious Buyer, Andrew Hawley from Vintage ... and the Doors International Ballroom at the Hilton Hotel ... the only time that Morrison's mother would see her ... 1967. According to Hawley, “This would be the Doors ... Alexandria Roller Rink earlier that year and would return ...
(Date:12/21/2014)... As testosterone therapy lawsuit filings ... and blood clots from using testosterone products such as ... shows that the male hormone testosterone may increase the ... published in the Proceedings of the National Academy of ... group of male rats with naturally occurring colon cancer. ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly bamboo ... its bamboo flooring promotion for the coming 2015. ... suppliers, and offers the best bamboo products and ... promotion, all customers can enjoy a special discount, ... know BambooIndustry.com from press releases. , The bamboo ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... ) that allege a metal-on-metal version of the ... move forward in state and federal courts, Bernstein ... in New Jersey’ Bergen County Superior Court on ... were permitted to begin deposition of plaintiffs on ...
Breaking Medicine News(10 mins):Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4
... premier educational gathering of the world,s leading laser experts hosted by ... ... Wausau, WI (PRWEB) November 20, 2008 -- The American Society ... National Harbor, Md., April 1 - 5, 2009     , , ...
... California reorganization plans , , ... this week in an advisory vote on two reorganization plans. ... whether they want to be part of a new single ... representing a broader classification of healthcare workers. , ...
... cancer survival are largely inaccurate because they widely disregard ... in addition to their primary cancer, says Jay Piccirillo, ... School of Medicine in St. Louis, the Siteman Cancer ... problem with cancer survival statistics, which generally don,t take ...
... Cyberonics, Inc. (Nasdaq: CYBX ),today announced results for the quarter ... , Results for the second quarter of ... , -- Net sales of $36.0 million, a 24% increase ... the epilepsy indication, increased by an estimated ...
... and slows the progression of AIDS, study confirms , , ... finalizes research that changed guidelines around the world regarding ... on preliminary findings released last year, several health agencies ... begin HIV treatment early in babies, instead of waiting ...
... congressional breakfast briefing on the subject of civic engagement ... as the closing session of the 61st Annual Scientific ... President-Elect Barack Obama has voiced support for an expanded ... are preparing to work quickly with congressional leaders to ...
Cached Medicine News:Health News:Announcing a Monumental Sharing of Laser Innovation: The American Society for Laser Medicine and Surgery (ASLMS) Holds 29th Annual Conference in National Harbor, Md., April 1 - 5, 2009 2Health News:Advisory Vote Begins on California Long-Term Care Local 2Health News:Survival of head and neck cancer patients is greatly affected by coexisting ailments 2Health News:Survival of head and neck cancer patients is greatly affected by coexisting ailments 3Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 2Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 3Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 4Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 5Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 6Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 7Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 8Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 9Health News:Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter 10Health News:Early HIV Treatment Best for Babies 2
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... , Dec. 19, 2014 In ... research and marketing communication tools are essential for ... competitive – consequently consumers, desires, preferences, and unmet ... environment, market research groups across all industries are ... communication tools. However, the adoption of new market ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... addition of the "Micro Market Monitor: North ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... is progressing steadily, which has resulted in fueling ... market. The main purpose of these dermatology devices ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3
... Nov. 1, 2011 Daylight Saving Time comes to an end ... altering sleep patterns. Sixty percent of Americans say that they experience ... the National Sleep Foundation,s 2011 Sleep in America poll, and for ... This season, fall back into bed for not only ...
... Calif., Nov. 1, 2011 Telik, Inc. (Nasdaq: ... studies on Telintra and related analogs at the 2011 ... and Cancer Therapeutics in San Francisco, California.  Details of ... Novel Ezatiostat analogues disrupt binding of GSTP1 to ...
Cached Medicine Technology:Keep the Time Change From Disrupting Your Rest With Sleep Formula 39™ 2Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2
... High Density, multi-frequency, linear flexible ... on the UST-5536, this "Omni-Plane ... sweeps horizontally as well as ... so that target lesions can ...
Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....
This is a 3D transducer for endovaginal imaging in OB/GYN....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Medicine Products: